Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06103565 · ClinicalTrials.gov registry record · NA

EHR Nudges to Improve Quality of Care in HF

A NA study of Heart Failure With Reduced Ejection Fraction, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT06103565 is a NA study of Heart Failure With Reduced Ejection Fraction that has completed, run by Northwestern University. The registered enrollment target is 3 participants, below the 3,966-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06103565, a NA study of Heart Failure With Reduced Ejection Fraction, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot feasibility study is to test a pharmacist-facing clinical decision support tool designed to increase adherence to guideline-directed medical therapy and evaluate the tool using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) evaluation framework.

Interventions

  • OTHER Clinical Decision Support Tool

Study Locations (1)

Illinois

  • Northwestern University Feinberg School of Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2025-05-13
Est. Completion 2025-08-13
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT06103565

The ClinicalTrials.gov registry entry for NCT06103565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,966-participant average among 27 other Heart Failure With Reduced Ejection Fraction trials with a reported enrollment target (100% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure With Reduced Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Clinical Decision Support Tool is the first listed.

NCT06103565 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06103565 about?

NCT06103565 is a clinical study titled "EHR Nudges to Improve Quality of Care in HF". The purpose of this pilot feasibility study is to test a pharmacist-facing clinical decision support tool designed to increase adherence to guideline-directed medical therapy and evaluate the tool using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) evaluation framework...

What is the current status of trial NCT06103565?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2025-05-13. Estimated completion is 2025-08-13.

What conditions does trial NCT06103565 study?

This clinical trial studies the following conditions: Heart Failure With Reduced Ejection Fraction.

What interventions are being tested in trial NCT06103565?

The interventions under investigation include: Clinical Decision Support Tool (OTHER).

Who is sponsoring clinical trial NCT06103565?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06103565 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure With Reduced Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.